Accordingly, LRPS-group had a higher frequency of mutation in UBR4, AHNAK, BOD1L1, and etc. In Bladder Cancer, mutation of AHNAK is one sign of favorable prognosis [48]. This evidence concerns the gene BOD1L1 and urinary bladder carcinoma.